A comprehensive view of Age 55+ / Seniors / Baby Boomers. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Chemicals Industry Market Intelligence Service.
Merck reports its next-generation pneumococcal shot V116 shows more effective immune response in older adults compared to its predecessor Pneumovax 23; V116 is effective against 83% of invasive pneumococcal diseases in older adults in the US
Published:
April 29, 2024
by FierceBiotech
|
CDC advises adults aged 65 and older to get updated COVID-19 vaccine dosage for protection against JN.1 and other circulating variants, four months after previous dose
Published:
April 26, 2024
by The American Hospital Association (AHA)
|
Sacroiliac joint fusion market forecast to grow at a CAGR of 18.6% by 2032 driven by aging population; population of US adults aged 65 and older expected to reach 95 million by 2060 according to CDC: DataHorizzon Research
Published:
April 22, 2024
by Financial Services Monitor Worldwide
|
GSK reports new long-term data show SHINGRIX vaccine continues to provide high protection against shingles in adults aged 50 and over for more than a decade
Published:
April 17, 2024
by GSK Group (GlaxoSmithKline)
|
New York senate bill would automatically apply digital-only coupons offered through grocers’ loyalty programs to senior citizens; bill aims to address trend of loyalty cards and newspaper coupons being replaced by mobile apps, which seniors may not use
Published:
April 15, 2024
by Supermarket News
|
Ask us about our Chemicals Industry market view